Rashed Assouma

Rashed Assouma

دبي دبي الإمارات العربية المتحدة
٣ آلاف متابع أكثر من 500 زميل

انضم للمتابعة
Elis Pharmaceuticals

نبذة عني

Experienced Chief Executive Officer in the field of investment, healthcare and media…

مقالات Rashed

النشاط

انضم الآن لعرض كل النشاط

الخبرة

  • Elis Pharmaceuticals

    Dubai, United Arab Emirates

  • -

    Dubai, United Arab Emirates

  • -

    Dubai, United Arab Emirates

  • -

التعليم

  • رسم بياني American University of Beirut

    American University of Beirut

    -

  • -

    Communication
    Customer service
    Developing people
    Leadership
    Managing change
    Negotiation
    Problem solving
    Raising productivity
    Strategic thinking
    Team building

  • -

المنشورات

  • Rashed Assouma – CEO, Elis Pharmaceuticals, UAE

    Pharmaboardroom

    My main advice would be to take the word “impossible” out of your vocabulary

    Elis Pharmaceuticals, a company that develops, manufactures and markets branded products and over the counter generic medications, continues to gain ground in the Middle East thanks to its distinctive approach. CEO Rashed Assouma takes us through the creation process of the company in the 2000s, how Elis has fostered collaboration with both governments and fellow industry players and explains his strategy to…

    My main advice would be to take the word “impossible” out of your vocabulary

    Elis Pharmaceuticals, a company that develops, manufactures and markets branded products and over the counter generic medications, continues to gain ground in the Middle East thanks to its distinctive approach. CEO Rashed Assouma takes us through the creation process of the company in the 2000s, how Elis has fostered collaboration with both governments and fellow industry players and explains his strategy to eventually become a publicly-traded company.

    عرض المنشور

  • Apricus Biosciences and Elis Pharma Sign License Agreement for Vitaros(R) in the Gulf and Part of the Middle East Apricus Bio to Receive up to $2.1 Million, Plus Royalties

    NASDAQ

    SAN DIEGO and DUBAI, Jan. 4, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) and Elis Pharmaceuticals, announced today that the two companies have entered into a licensing agreement granting Elis the exclusive rights to market Apricus Bio's new drug for erectile dysfunction, Vitaros®, in the Gulf and part of the Middle East. "This new agreement is the next step in our strategy of seeking to partner Vitaros in more than 100 countries around the world," said Dr…

    SAN DIEGO and DUBAI, Jan. 4, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) and Elis Pharmaceuticals, announced today that the two companies have entered into a licensing agreement granting Elis the exclusive rights to market Apricus Bio's new drug for erectile dysfunction, Vitaros®, in the Gulf and part of the Middle East. "This new agreement is the next step in our strategy of seeking to partner Vitaros in more than 100 countries around the world," said Dr. Bassam Damaj, President and Chief Executive Officer of Apricus Bio.

    The drug was approved by Health Canada in November as the first topical treatment for erectile dysfunction ("ED") for marketing in Canada. This validation will also make it possible to register the drug in other countries that recognize Canadian approval. The application for approval to market Vitaros in the territory licensed to Elis is scheduled to be filed in the first half of 2011.

    Under the terms of the agreement, Elis has exclusive rights in The Gulf Countries and part of the Middle East to commercialize and market Vitaros. Apricus Bio is entitled to receive up to $2.1 million in payments for signing, regulatory and sales milestones. Further, Apricus Bio will receive tiered double digit royalties based on Elis's sales of the product. "We are delighted to reach another major milestone in the history of this product," said Dr. Damaj. "This is another partnership in a series of commercialization agreements which we plan to execute for Vitaros. With their proven success in building new markets, Elis is a great partner for launching this product in The Gulf Countries and part of the Middle East."

    "This exciting collaboration allows Elis to expand into a complementary therapeutic area utilizing its proven sales and marketing expertise," said Rashed Assouma, Chief Executive Officer of Elis. "We believe that Vitaros has the potential to be an important new therapy for ED in our region."

    عرض المنشور

  • Elis Pharmaceuticals Ltd. and Heyltex Corporation hold scientific meeting with UAE Government at PABME 2010

    PABME

    Elis Pharmaceuticals, along with Heyltex Corporation, a US-based company specialising in the sales, marketing, and distribution of niche pharmaceuticals, yesterday held a successful scientific meeting with leading health officials from the UAE.

    Attendees included representatives from the UAE Ministry of Health, Dubai Health Authority, Health Authority – Abu Dhabi, and from Bahrain and Saudi Arabia. The health authorities were invited to attend the meeting to discuss the latest in…

    Elis Pharmaceuticals, along with Heyltex Corporation, a US-based company specialising in the sales, marketing, and distribution of niche pharmaceuticals, yesterday held a successful scientific meeting with leading health officials from the UAE.

    Attendees included representatives from the UAE Ministry of Health, Dubai Health Authority, Health Authority – Abu Dhabi, and from Bahrain and Saudi Arabia. The health authorities were invited to attend the meeting to discuss the latest in radiology protection drugs with the aim of stockpiling these antidotes in case of incident or accident involving radiation harmful to humans.
    “Immediate access to required antidotes in the event of a catastrophic incident, such as a dirty bomb explosion or a nuclear accident, is crucial for emergency planning,” said Alexander Heyl, CEO, Heyltex. “Emergency physicians, nurses, and EMS personnel need to be prepared for a number of emergency events. Specific antidotes might not be readily available in required quantities after a major catastrophic event takes place, unless pharmaceutical stockpiling has been planned and executed well in advance.”

المشروعات

  • Achieved over 500 million USD in infrastructural water pipeline, water treatment & construction projects in Africa

    ⁩ - الحالي

  • Homepital Telehealth for the MENA region

    ⁩ - الحالي

    Launched with Injazat for the "Department of Health" in Abu Dhabi, under the name of "DOH Remote Care"

    عرض المشروع

التكريمات والمكافآت

  • Ministry of Defence

    Ministry of Defence

    The Ministry Of Defense in UAE Awarded Rashed Assouma for conducting research and lecture about medication for Nuclear & Radiation Protection

  • WHO'S WHO Honored Member

    INTERNATIONAL WHO'S WHO

    International WHO'S WHO Historical Society
    recognizes Rashed Assouma as one of its newest members to appear in the 2013 edition of International WHO'S WHO of Professionals, having demonstrated exemplary achievement and distinguished contributions to the business community.

  • Ministry of Defence

    Ministry of Defence in UAE

    Elis has the Honor to organize a Lecture with Ministry of Defense in United Arab Emirates
    Coping with Radiation Exposure: A Growing Risk
    Antidote Stockpiling & Radiological
    Public Health Emergencies

    The Ministry Of Defense in UAE Awarded Mr. Rashed Assouma for the successful achievement.

اللغات

  • Arabic

    إجادة اللغة الأم أو إجادة لغتين إجادة تامة

  • English

    إجادة كاملة

  • French

    إجادة تامة على المستوى المهني

التوصيات المستلمة

شخص واحد قدم توصية لـRashed

انضم الآن لعرض

المزيد من أنشطة Rashed

عرض ملف Rashed الشخصي الكامل

  • مشاهدة الأشخاص المشتركين الذين تعرفهم
  • تقديم تعارف
  • تواصل مع Rashed مباشرة
انضم لعرض الملف الشخصي الكامل

ملفات شخصية أخرى مشابهة

استكشاف مزيد من المنشورات

أعضاء آخرون يحملون اسم ⁦⁩Rashed Assouma

2 أخرى باسمRashed Assouma على LinkedIn

استعرض الأعضاء الآخرين الذين يحملون اسم ⁦⁩Rashed Assouma

اكتسب مهارات جديدة من خلال هذه المواد الدراسية

عرض كل الدورات